GLP-1 Market Size, Key Players, and the Race to Solve Compliance
Oral formulations may solve the compliance crisis that injections cannot.
Saoirse Dunleavy
Staff Writer, Patient Access & Outcomes
Saoirse Dunleavy is a health journalist and former clinical trial coordinator whose 2009 work on diabetes self-management programs in rural Ireland shaped her ongoing interest in the human side of chronic disease care. She now covers how real-world adherence challenges shape drug design decisions and reimbursement debates.
1 story
Oral formulations may solve the compliance crisis that injections cannot.